BUZZ-West Pharma falls as 2025 profit, revenue forecast below estimates

Updates

Shares of medical equipment maker West Pharmaceutical Services WST.N fall as much as 31.7% to an over-two-year low of $220

Co sees 2025 adj profit between $6 and $6.20 per share, missing analysts avg estimate of $7.44 per share - LSEG

Sees 2025 sales between $2.88 bln and $2.91 bln, below estimates of $3.04 bln

Posts Q4 adj profit of $1.82 per share vs analysts avg estimate of $1.72 per share

Posts Q4 sales of $748.8 mln vs analysts avg estimate of $740.47 mln

In the last 12 months, WST has fallen ~21%